Research peptide suppliers: Injectable GHK-Cu is available as a lyophilized powder from research peptide companies
Try lower doses or earlier administration to allow effects to dissipate before wake time
Schmidt C, Wiedmann F, Zhou XB, Heijman J, Voigt N, Ratte A, Lang S, Kallenberger SM, Campana C, Weymann A, De Simone R, Szabo G, Ruhparwar A, Kallenbach K, Karck M, Ehrlich JR, Baczko I, Borggrefe M, Ravens U, Dobrev D, Katus HA, Thomas D (2017) Inverse remodelling of K 2P 3.1 K + channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy
Yes survodutide reduced liver fat content by 55% in participants with NASH, measured via MRI-PDFF in Phase 2 trials